Financhill
Back

Akero Therapeutics Quote, Financials, Valuation and Earnings

Akero Therapeutics Price Quote

$30.97
-0.14 (-0.45%)
(Updated: December 9, 2024 at 10:55 AM ET)

Akero Therapeutics Key Stats

Buy
65
Akero Therapeutics (AKRO) is a Buy

Day range:
$29.58 - $31.34
52-week range:
$15.32 - $37.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.94%

Volume:
506.9K
Avg. volume:
652.2K
1-year change:
63.22%
Market cap:
$2.2B
Revenue:
$0
EPS:
$-3.78

How Much Does Akero Therapeutics Make?

Data Unavailable

Is Akero Therapeutics Growing As A Company?

Data Unavailable

Akero Therapeutics Stock Price Performance

What Is Akero Therapeutics 52-Week High & Low?

Akero Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akero Therapeutics?

Is Akero Therapeutics Cash Flow Positive?

  • What Is AKRO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$211.6M
  • What Is Akero Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $370.4M
  • What Is Akero Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$112.2M

Akero Therapeutics Return On Invested Capital

Data Unavailable

Akero Therapeutics Earnings Date & Stock Price

Akero Therapeutics Competitors

  • Who Are Akero Therapeutics's Competitors?
    Below is a list of companies who compete with Akero Therapeutics or are related in some way:
    • 89bio Inc (ETNB)
    • iBio Inc (IBIO)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Akero Therapeutics Dividend Yield

Akero Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.36%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 48.27
Upside from Last Price: 55.17%

Major Shareholders

  • How many AKRO shares are owned by institutional investors?
    115.8M AKRO shares are owned by institutional investors
  • How many AKRO shares are owned by insiders?
    1.3M AKRO shares are owned by insiders